(en) US Preventive Services Task Force (USPSTF), « Screening for Prostate Cancer », sur www.ahrq.gov, Agency for Healthcare Research and Quality, .
ascopubs.org
jco.ascopubs.org
E. Basch, T.K. Oliver, A. Vickers, I. Thompson, P. Kantoff, H. Parnes, D.A. Loblaw, Roth, B., Williams, J et Nam, RK, « Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion. », Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, no 24, , p. 3020–5 (PMID22802323, PMCID3776923, DOI10.1200/JCO.2012.43.3441, lire en ligne).
(en) K.L. Greene, P.C. Albertsen, R.J. Babaian, H.B. Carter, P.H. Gann, M. Han, D.A. Kuban, A.O. Sartor, J.L. Stanford, A. Zietman et P. Carroll, « Prostate specific antigen best practice statement: 2009 update », The Journal of Urology, American Urological Association, vol. 189, no 1 suppl., , S2–S11 (PMID23234625, DOI10.1016/j.juro.2012.11.014).
(en) A.M. Wolf, R.C. Wender, R.B. Etzioni, I.M. Thompson, A.V. D'Amico, R.J. Volk, D.D. Brooks, C. Dash, I. Guessous, K. Andrews, C. DeSantis et R.A. Smith, « American Cancer Society guideline for the early detection of prostate cancer: update 2010 », CA: a cancer journal for clinicians, American Cancer Society Prostate Cancer Advisory, Committee, vol. 60, no 2, mars–april 2010, p. 70–98 (PMID20200110, DOI10.3322/caac.20066).
E. Basch, T.K. Oliver, A. Vickers, I. Thompson, P. Kantoff, H. Parnes, D.A. Loblaw, Roth, B., Williams, J et Nam, RK, « Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion. », Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, no 24, , p. 3020–5 (PMID22802323, PMCID3776923, DOI10.1200/JCO.2012.43.3441, lire en ligne).
(en) Hal R. Arkes et Wolfgang Gaissmaier, « Psychological Research and the Prostate-Cancer Screening Controversy », Psychological Science, vol. 23, no 6, , p. 547-553 (DOI10.1177/0956797612437428, résumé).
(en) Gerald L. Andriole, E. David Crawford, Robert L. Grubb, Saundra S. Buys, David Chia, Timothy R. Church, Mona N. Fouad, Edward P. Gelmann et Paul A. Kvale, « Mortality Results from a Randomized Prostate-Cancer Screening Trial », The New England Journal of Medicine, vol. 360, no 13, , p. 1310–1319 (PMID19297565, PMCID2944770, DOI10.1056/NEJMoa0810696, lire en ligne).
(en) M.R. Cooperberg et P.R. Carroll, « Prostate cancer screening », The New England Journal of Medicine, vol. 361, no 2, , p. 203 (PMID19593852, DOI10.1056/nejmc090849).
(en) Paul Pinsky, A. Black, B. S. Kramer, A. Miller, P. C. Prorok et C. Berg, « Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial », Clinical Trials, vol. 7, no 4, , p. 303–11 (PMID20571134, DOI10.1177/1740774510374091).
(en) A. Tewari, P. Sooriakumaran, D.A. Bloch, U. Seshadri-Kreaden, A.E. Hebert et P. Wiklund, « Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy », European Urology, vol. 62, no 1, , p. 1–15 (PMID22405509, DOI10.1016/j.eururo.2012.02.029).
(en) Scales C., Curtis L., Norris R., Schulman K., Albala D., Moul J., « Prostate specific antigen testing in men older than 75 years in the United States », The Journal of Urology, vol. 176, no 2, , p. 511–4 (PMID16813879, DOI10.1016/j.juro.2006.03.060).
(en) M.R. Cooperberg, P.R. Carroll et L. Klotz, « Active surveillance for prostate cancer: progress and promise », Journal of clinical oncology, vol. 29, no 27, , p. 3669–3676 (PMID21825257, DOI10.1200/JCO.2011.34.9738).
(en) R. Siegel, Elizabeth Ward, Otis Brawley et Ahmedin Jemal, « Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths », CA – A Cancer Journal for Clinicians, vol. 61, no 4, , p. 212–36 (PMID21685461, DOI10.3322/caac.20121).
(en) P.R. Carroll, J. M. Whitson et M. R. Cooperberg, « Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? », Journal of Clinical Oncology, vol. 29, no 4, , p. 345–7 (PMID21189396, DOI10.1200/JCO.2010.32.5308).
(en) Ross .LE., Coates R.J., Breen N., Uhler R.J., Potosky A.L., Blackman D., « Prostate-specific antigen test use reported in the 2000 National Health Interview Survey », Preventive Medicine, vol. 38, no 6, , p. 732–44 (PMID15193893, DOI10.1016/j.ypmed.2004.01.005).
(en) Fritz H. Schröderet al., « Screening and Prostate-Cancer Mortality in a Randomized European Study », NEJM, vol. 360, no 13, , p. 1320–8 (PMID19297566, DOI10.1056/NEJMoa0810084, lire en ligne).
(en) Monique Roobol, Melissa Kerkhof, Fritz H. Schröder, Jack Cuzick, Peter Sasieni, Matti Hakama, Ulf Hakan Stenman, Stefano Ciatto et Vera Nelen, « Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) », European Urology, vol. 56, no 4, , p. 584–91 (PMID19660851, DOI10.1016/j.eururo.2009.07.018).
(en) R. Gulati, Angela B. Mariotto, Shu Chen, John L. Gore et Ruth Etzioni, « Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates », Journal of Clinical Epidemiology, vol. 64, no 12, , p. 1412–17 (PMID22032753, DOI10.1016/j.jclinepi.2011.06.011).
(en) P.J. Van Leeuwen et al, « Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit », European Journal of Cancer, vol. 46, no 2, , p. 377–383 (PMID19804966, DOI10.1016/j.ejca.2009.09.008).
(en) Gerald L. Andriole, E. David Crawford, Robert L. Grubb, Saundra S. Buys, David Chia, Timothy R. Church, Mona N. Fouad, Edward P. Gelmann et Paul A. Kvale, « Mortality Results from a Randomized Prostate-Cancer Screening Trial », The New England Journal of Medicine, vol. 360, no 13, , p. 1310–1319 (PMID19297565, PMCID2944770, DOI10.1056/NEJMoa0810696, lire en ligne).
(en) Fritz H. Schröderet al., « Screening and Prostate-Cancer Mortality in a Randomized European Study », NEJM, vol. 360, no 13, , p. 1320–8 (PMID19297566, DOI10.1056/NEJMoa0810084, lire en ligne).
news-medical.net
(en) « AUA clarifes recommendations on prostate cancer testing with PSA test and DRE », The Medical News', (lire en ligne).
(en) K.L. Greene, P.C. Albertsen, R.J. Babaian, H.B. Carter, P.H. Gann, M. Han, D.A. Kuban, A.O. Sartor, J.L. Stanford, A. Zietman et P. Carroll, « Prostate specific antigen best practice statement: 2009 update », The Journal of Urology, American Urological Association, vol. 189, no 1 suppl., , S2–S11 (PMID23234625, DOI10.1016/j.juro.2012.11.014).
(en) A.M. Wolf, R.C. Wender, R.B. Etzioni, I.M. Thompson, A.V. D'Amico, R.J. Volk, D.D. Brooks, C. Dash, I. Guessous, K. Andrews, C. DeSantis et R.A. Smith, « American Cancer Society guideline for the early detection of prostate cancer: update 2010 », CA: a cancer journal for clinicians, American Cancer Society Prostate Cancer Advisory, Committee, vol. 60, no 2, mars–april 2010, p. 70–98 (PMID20200110, DOI10.3322/caac.20066).
E. Basch, T.K. Oliver, A. Vickers, I. Thompson, P. Kantoff, H. Parnes, D.A. Loblaw, Roth, B., Williams, J et Nam, RK, « Screening for Prostate Cancer With Prostate-Specific Antigen Testing: American Society of Clinical Oncology Provisional Clinical Opinion. », Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 30, no 24, , p. 3020–5 (PMID22802323, PMCID3776923, DOI10.1200/JCO.2012.43.3441, lire en ligne).
(en) Gerald L. Andriole, E. David Crawford, Robert L. Grubb, Saundra S. Buys, David Chia, Timothy R. Church, Mona N. Fouad, Edward P. Gelmann et Paul A. Kvale, « Mortality Results from a Randomized Prostate-Cancer Screening Trial », The New England Journal of Medicine, vol. 360, no 13, , p. 1310–1319 (PMID19297565, PMCID2944770, DOI10.1056/NEJMoa0810696, lire en ligne).
(en) M.R. Cooperberg et P.R. Carroll, « Prostate cancer screening », The New England Journal of Medicine, vol. 361, no 2, , p. 203 (PMID19593852, DOI10.1056/nejmc090849).
(en) Paul Pinsky, A. Black, B. S. Kramer, A. Miller, P. C. Prorok et C. Berg, « Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial », Clinical Trials, vol. 7, no 4, , p. 303–11 (PMID20571134, DOI10.1177/1740774510374091).
(en) A. Tewari, P. Sooriakumaran, D.A. Bloch, U. Seshadri-Kreaden, A.E. Hebert et P. Wiklund, « Positive surgical margin and perioperative complication rates of primary surgical treatments for prostate cancer: a systematic review and meta-analysis comparing retropubic, laparoscopic, and robotic prostatectomy », European Urology, vol. 62, no 1, , p. 1–15 (PMID22405509, DOI10.1016/j.eururo.2012.02.029).
(en) Scales C., Curtis L., Norris R., Schulman K., Albala D., Moul J., « Prostate specific antigen testing in men older than 75 years in the United States », The Journal of Urology, vol. 176, no 2, , p. 511–4 (PMID16813879, DOI10.1016/j.juro.2006.03.060).
(en) M.R. Cooperberg, P.R. Carroll et L. Klotz, « Active surveillance for prostate cancer: progress and promise », Journal of clinical oncology, vol. 29, no 27, , p. 3669–3676 (PMID21825257, DOI10.1200/JCO.2011.34.9738).
(en) R. Siegel, Elizabeth Ward, Otis Brawley et Ahmedin Jemal, « Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths », CA – A Cancer Journal for Clinicians, vol. 61, no 4, , p. 212–36 (PMID21685461, DOI10.3322/caac.20121).
(en) P.R. Carroll, J. M. Whitson et M. R. Cooperberg, « Serum prostate-specific antigen for the early detection of prostate cancer: always, never, or only sometimes? », Journal of Clinical Oncology, vol. 29, no 4, , p. 345–7 (PMID21189396, DOI10.1200/JCO.2010.32.5308).
(en) L.G. Gomella, X.S. Liu, E.J. Trabulsi, W.K. Kelly, R. Myers, T. Showalter, A. Dicker et R. Wender, « Screening for prostate cancer: the current evidence and guidelines controversy », The Canadian Journal of Urology, vol. 18, no 5, , p. 5875-83 (PMID22018148, lire en ligne)modifier
(en) Ross .LE., Coates R.J., Breen N., Uhler R.J., Potosky A.L., Blackman D., « Prostate-specific antigen test use reported in the 2000 National Health Interview Survey », Preventive Medicine, vol. 38, no 6, , p. 732–44 (PMID15193893, DOI10.1016/j.ypmed.2004.01.005).
(en) Fritz H. Schröderet al., « Screening and Prostate-Cancer Mortality in a Randomized European Study », NEJM, vol. 360, no 13, , p. 1320–8 (PMID19297566, DOI10.1056/NEJMoa0810084, lire en ligne).
(en) Monique Roobol, Melissa Kerkhof, Fritz H. Schröder, Jack Cuzick, Peter Sasieni, Matti Hakama, Ulf Hakan Stenman, Stefano Ciatto et Vera Nelen, « Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) », European Urology, vol. 56, no 4, , p. 584–91 (PMID19660851, DOI10.1016/j.eururo.2009.07.018).
(en) R. Gulati, Angela B. Mariotto, Shu Chen, John L. Gore et Ruth Etzioni, « Long-term projections of the harm-benefit trade-off in prostate cancer screening are more favorable than previous short-term estimates », Journal of Clinical Epidemiology, vol. 64, no 12, , p. 1412–17 (PMID22032753, DOI10.1016/j.jclinepi.2011.06.011).
(en) P.J. Van Leeuwen et al, « Prostate cancer mortality in screen and clinically detected prostate cancer: Estimating the screening benefit », European Journal of Cancer, vol. 46, no 2, , p. 377–383 (PMID19804966, DOI10.1016/j.ejca.2009.09.008).
(en) Hal R. Arkes et Wolfgang Gaissmaier, « Psychological Research and the Prostate-Cancer Screening Controversy », Psychological Science, vol. 23, no 6, , p. 547-553 (DOI10.1177/0956797612437428, résumé).
urofrance.org
Arnauld Villers, Xavier Rébillard, Michel Soulié, Jean-Louis Davin, Patrick Coloby, Jean-Luc Moreau, Arnaud Méjean, Jacques Irani, Christian Coulange, Philippe Mangin, « Dépistage du cancer de la prostate », Association française d'urologie (AFU), (consulté le ).
(en) L.G. Gomella, X.S. Liu, E.J. Trabulsi, W.K. Kelly, R. Myers, T. Showalter, A. Dicker et R. Wender, « Screening for prostate cancer: the current evidence and guidelines controversy », The Canadian Journal of Urology, vol. 18, no 5, , p. 5875-83 (PMID22018148, lire en ligne)modifier